This content is in French.
A practical look at HCM in young athletes
13 février 2026
By Carolina Lima | Published on February 13, 2026 | 3 min readHypertrophic cardiomyopathy (HCM) remains a major concern in sports cardiology because it is among the leading causes of sudden cardiac death (SCD) in young competitive athletes. In a large US registry of 1,866 athlete deaths, HCM accounted for nearly 40% of cases, most occurring in adolescents still in high school. More than 80% of the
By Carolina Lima | Published on February 13, 2026 | 3 min read
Hypertrophic cardiomyopathy (HCM) remains a major concern in sports cardiology because it is among the leading causes of sudden cardiac death (SCD) in young competitive athletes. In a large US registry of 1,866 athlete deaths, HCM accounted for nearly 40% of cases, most occurring in adolescents still in high school. More than 80% of these individuals were asymptomatic prior to collapse, underscoring how difficult it is to identify HCM before catastrophic events occur.
Hypertrophic cardiomyopathy (HCM) remains a major concern in sports cardiology because it is among the leading causes of sudden cardiac death (SCD) in young competitive athletes. In a large US registry of 1,866 athlete deaths, HCM accounted for nearly 40% of cases, most occurring in adolescents still in high school. More than 80% of these individuals were asymptomatic prior to collapse, underscoring how difficult it is to identify HCM before catastrophic events occur.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Malhotra A, Sharma S. Hypertrophic cardiomyopathy in athletes. European Cardiology Review. 2017;12(2):80–82. doi:10.15420/ecr.2017:12:1.
View the source
